These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31575647)

  • 1.
    St-Jean G; Tsoi M; Abedini A; Levasseur A; Rico C; Morin M; Djordjevic B; Miinalainen I; Kaarteenaho R; Paquet M; Gévry N; Boyer A; Vanderhyden B; Boerboom D
    Development; 2019 Oct; 146(20):. PubMed ID: 31575647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the Hippo/TAZ pathway is required for menstrual stem cells to suppress myofibroblast and inhibit transforming growth factor β signaling in human endometrial stromal cells.
    Zhu H; Pan Y; Jiang Y; Li J; Zhang Y; Zhang S
    Hum Reprod; 2019 Apr; 34(4):635-645. PubMed ID: 30715393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Disruption of Lats1 and Lats2 in Mice Impairs Adrenal Cortex Development and Alters Adrenocortical Cell Fate.
    Ménard A; Abou Nader N; Levasseur A; St-Jean G; Le Roy MLG; Boerboom D; Benoit-Biancamano MO; Boyer A
    Endocrinology; 2020 May; 161(5):. PubMed ID: 32243503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential roles of mesenchyme-derived beta-catenin in mouse Müllerian duct morphogenesis.
    Deutscher E; Hung-Chang Yao H
    Dev Biol; 2007 Jul; 307(2):227-36. PubMed ID: 17532316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LATS1/2 control TGFB-directed epithelial-to-mesenchymal transition in the murine dorsal cranial neuroepithelium through YAP regulation.
    Martínez Traverso IM; Steimle JD; Zhao X; Wang J; Martin JF
    Development; 2022 Sep; 149(18):. PubMed ID: 36125128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippo pathway deletion in adult resting cardiac fibroblasts initiates a cell state transition with spontaneous and self-sustaining fibrosis.
    Xiao Y; Hill MC; Li L; Deshmukh V; Martin TJ; Wang J; Martin JF
    Genes Dev; 2019 Nov; 33(21-22):1491-1505. PubMed ID: 31558567
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Tsoi M; Morin M; Rico C; Johnson RL; Paquet M; Gévry N; Boerboom D
    FASEB J; 2019 Oct; 33(10):10819-10832. PubMed ID: 31268774
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Li L; Dong L; Wang Y; Zhang X; Yan J
    Biomed Res Int; 2018; 2018():4387932. PubMed ID: 30671453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Disruption of Lats1 and Lats2 in Mice Impairs Testis Development and Alters Somatic Cell Fate.
    Abou Nader N; Ménard A; Levasseur A; St-Jean G; Boerboom D; Zamberlam G; Boyer A
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of Lats1 and Lats2 highlights the role of hippo pathway effector YAP in larynx and vocal fold epithelium morphogenesis.
    Mohad V; Lungova V; Verheyden J; Thibeault SL
    Dev Biol; 2021 May; 473():33-49. PubMed ID: 33515576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Catenin is essential for Müllerian duct regression during male sexual differentiation.
    Kobayashi A; Stewart CA; Wang Y; Fujioka K; Thomas NC; Jamin SP; Behringer RR
    Development; 2011 May; 138(10):1967-75. PubMed ID: 21490063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific deletion of LKB1/
    George JW; Patterson AL; Tanwar PS; Kajdacsy-Balla A; Prins GS; Teixeira JM
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3445-3450. PubMed ID: 28289208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of WNT inhibitory factor 1 expression by Müllerian inhibiting substance/antiMullerian hormone in the Müllerian duct mesenchyme is linked to Müllerian duct regression.
    Park JH; Tanaka Y; Arango NA; Zhang L; Benedict LA; Roh MI; Donahoe PK; Teixeira JM
    Dev Biol; 2014 Feb; 386(1):227-36. PubMed ID: 24362065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
    Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
    Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional redundancy of TGF-beta family type I receptors and receptor-Smads in mediating anti-Mullerian hormone-induced Mullerian duct regression in the mouse.
    Orvis GD; Jamin SP; Kwan KM; Mishina Y; Kaartinen VM; Huang S; Roberts AB; Umans L; Huylebroeck D; Zwijsen A; Wang D; Martin JF; Behringer RR
    Biol Reprod; 2008 Jun; 78(6):994-1001. PubMed ID: 18322278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid signaling determines the fate of uterine stroma in the mouse Müllerian duct.
    Nakajima T; Iguchi T; Sato T
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14354-14359. PubMed ID: 27911779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity.
    Moroishi T; Hayashi T; Pan WW; Fujita Y; Holt MV; Qin J; Carson DA; Guan KL
    Cell; 2016 Dec; 167(6):1525-1539.e17. PubMed ID: 27912060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMOylation of large tumor suppressor 1 at Lys751 attenuates its kinase activity and tumor-suppressor functions.
    Mei L; Yuan L; Shi W; Fan S; Tang C; Fan X; Yang W; Qian Y; Hussain M; Wu X
    Cancer Lett; 2017 Feb; 386():1-11. PubMed ID: 27847303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTNNB1 in mesenchyme regulates epithelial cell differentiation during Müllerian duct and postnatal uterine development.
    Stewart CA; Wang Y; Bonilla-Claudio M; Martin JF; Gonzalez G; Taketo MM; Behringer RR
    Mol Endocrinol; 2013 Sep; 27(9):1442-54. PubMed ID: 23904126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial Müllerian Duct Retention in Smad4 Conditional Mutant Male Mice.
    Petit FG; Deng C; Jamin SP
    Int J Biol Sci; 2016; 12(6):667-76. PubMed ID: 27194944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.